Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.42 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 79/100

Baxter International Inc at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 06:00PM GMT
Release Date Price: $89.37 (+4.04%)
Robert Justin Marcus
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. I'm Robbie Marcus, the Medtech analyst at J.P. Morgan. I'm very happy to introduce Baxter's CEO, Joe Almeida. Joe, happy to have you.

JosÃ;E. Almeida
Baxter International Inc. - Chairman, President & CEO

© -

Thank you, Robbie. Thank you. Good morning. Robbie, thank you for having us here. I would like to start with our safe harbor statement, it's a very long one and encourage you to take your time in our website to read it, will take you about an hour.

Let me tell you a little bit about Baxter. Baxter is an 85-year-old company. It's been in the business for a long time and operates in the very critical areas of health care, first, by medically necessary products. You go to any hospital, you see an IV bag from Baxter; you go to people who have ESRD at home, they will have solutions and cyclers from Baxter. We are in the home. We are in the hospital. Within the hospital, we're in the ICU. We are in general ward floors, emergency rooms.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot